axt-1003
Showing 1 - 1 of 1
Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)
Not yet recruiting
- Relapsed or Refractory Non-Hodgkin's Lymphoma
- AXT-1003
-
Beijing, China
- +3 more
Jul 20, 2023